Table of Contents

Executive Summary

1 Industry Overview of Bronchodilators

• 1.1 Definition of Bronchodilators
• 1.2 Bronchodilators Segment by Type
  • 1.2.1 Global Bronchodilators Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Anticholinergic Bronchodilators
  • 1.2.3 Adrenergic Bronchodilators
  • 1.2.4 Bronchodilator Combinations
  • 1.2.5 Methylxanthines
• 1.3 Bronchodilators Segment by Applications
  • 1.3.1 Global Bronchodilators Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Asthma
  • 1.3.3 COPD
  • 1.3.4 Others
• 1.4 Global Bronchodilators Overall Market
  • 1.4.1 Global Bronchodilators Revenue (2014-2025)
  • 1.4.2 Global Bronchodilators Production (2014-2025)
  • 1.4.3 North America Bronchodilators Status and Prospect (2014-2025)
  • 1.4.4 Europe Bronchodilators Status and Prospect (2014-2025)
  • 1.4.5 China Bronchodilators Status and Prospect (2014-2025)
  • 1.4.6 Japan Bronchodilators Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Bronchodilators Status and Prospect (2014-2025)
  • 1.4.8 India Bronchodilators Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Bronchodilators
• 2.3 Manufacturing Process Analysis of Bronchodilators
• 2.4 Industry Chain Structure of Bronchodilators

3 Development and Manufacturing Plants Analysis of Bronchodilators

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Bronchodilators Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Bronchodilators
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Bronchodilators Production and Capacity Analysis
• 4.2 Bronchodilators Revenue Analysis
• 4.3 Bronchodilators Price Analysis
• 4.4 Market Concentration Degree

5 Bronchodilators Regional Market Analysis

• 5.1 Bronchodilators Production by Regions
  • 5.1.1 Global Bronchodilators Production by Regions
  • 5.1.2 Global Bronchodilators Revenue by Regions
• 5.2 Bronchodilators Consumption by Regions
• 5.3 North America Bronchodilators Market Analysis
  • 5.3.1 North America Bronchodilators Production
  • 5.3.2 North America Bronchodilators Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Bronchodilators Import and Export
• 5.4 Europe Bronchodilators Market Analysis
  • 5.4.1 Europe Bronchodilators Production
  • 5.4.2 Europe Bronchodilators Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Bronchodilators Import and Export
• 5.5 China Bronchodilators Market Analysis
  • 5.5.1 China Bronchodilators Production
  • 5.5.2 China Bronchodilators Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Bronchodilators Import and Export
• 5.6 Japan Bronchodilators Market Analysis
  • 5.6.1 Japan Bronchodilators Production
  • 5.6.2 Japan Bronchodilators Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Bronchodilators Import and Export
• 5.7 Southeast Asia Bronchodilators Market Analysis
  • 5.7.1 Southeast Asia Bronchodilators Production
  • 5.7.2 Southeast Asia Bronchodilators Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Bronchodilators Import and Export
• 5.8 India Bronchodilators Market Analysis
  • 5.8.1 India Bronchodilators Production
  • 5.8.2 India Bronchodilators Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Bronchodilators Import and Export

6 Bronchodilators Segment Market Analysis (by Type)

• 6.1 Global Bronchodilators Production by Type
• 6.2 Global Bronchodilators Revenue by Type
• 6.3 Bronchodilators Price by Type

7 Bronchodilators Segment Market Analysis (by Application)

• 7.1 Global Bronchodilators Consumption by Application
• 7.2 Global Bronchodilators Consumption Market Share by Application (2014-2019)

8 Bronchodilators Major Manufacturers Analysis

• 8.1 AstraZeneca
  • 8.1.1 AstraZeneca Bronchodilators Production Sites and Area Served
  • 8.1.2 AstraZeneca Product Introduction, Application and Specification
  • 8.1.3 AstraZeneca Bronchodilators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Boehringer Ingelheim
  • 8.2.1 Boehringer Ingelheim Bronchodilators Production Sites and Area Served
  • 8.2.2 Boehringer Ingelheim Product Introduction, Application and Specification
  • 8.2.3 Boehringer Ingelheim Bronchodilators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 GlaxoSmithKline
  • 8.3.1 GlaxoSmithKline Bronchodilators Production Sites and Area Served
  • 8.3.2 GlaxoSmithKline Product Introduction, Application and Specification
  • 8.3.3 GlaxoSmithKline Bronchodilators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 F. Hoffmann-La Roche
  • 8.4.1 F. Hoffmann-La Roche Bronchodilators Production Sites and Area Served
  • 8.4.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
  • 8.4.3 F. Hoffmann-La Roche Bronchodilators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served

9 Development Trend of Analysis of Bronchodilators Market

• 9.1 Global Bronchodilators Market Trend Analysis
  • 9.1.1 Global Bronchodilators Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Bronchodilators Regional Market Trend
  • 9.2.1 North America Bronchodilators Forecast 2019-2025
  • 9.2.2 Europe Bronchodilators Forecast 2019-2025
  • 9.2.3 China Bronchodilators Forecast 2019-2025
  • 9.2.4 Japan Bronchodilators Forecast 2019-2025
  • 9.2.5 Southeast Asia Bronchodilators Forecast 2019-2025
  • 9.2.6 India Bronchodilators Forecast 2019-2025
• 9.3 Bronchodilators Market Trend (Product Type)
• 9.4 Bronchodilators Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Bronchodilators Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription. Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma.
Increase in prevalence of pulmonary disorders, smoking, and junk food fuel the bronchodilators market growth. In addition, rise in disposable income, geriatric population, and increase in awareness of healthcare among population are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of the bronchodilators hinder the market. Ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.
North America is expected to be the largest market for bronchodilators due to high incidence rate of diseases such as COPD and asthma, high demand for bronchodilator drugs, and increase in awareness. Europe holds the second largest market share. The Asia Pacific market is expected to provide a lucrative opportunity during the forecast period due to increasing disease burden, growing biopharmaceutical industry, and rising research activity along with competitive landscape in the pharmaceutical industry. The market in Latin America and Middle East & Africa is anticipated to grow owing to increasing health care infrastructure and growing public-private collaboration to expand the health care sector.

The global Bronchodilators market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Bronchodilators volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bronchodilators market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bronchodilators in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bronchodilators manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline
F. Hoffmann-La Roche
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Anticholinergic Bronchodilators
Adrenergic Bronchodilators
Bronchodilator Combinations
Methylxanthines

Segment by Application
Asthma
COPD
Others